Arama Sonuçları Strategy - Daraltılmış: Drug development.SirsiDynix Enterprisehttps://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dStrategy$0026qf$003dSUBJECT$002509Subject$002509Drug$002bdevelopment.$002509Drug$002bdevelopment.$0026ic$003dtrue$0026ps$003d300?2026-02-23T06:01:52ZBiomarkers in drug discovery and development : a handbook of practice, application, and strategyent://SD_ILS/0/SD_ILS:5960002026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Rahbari, Ramin, 1965- editor. Van Niewaal, Jonathan, 1979- editor. Bleavins, Michael R., editor.<br/>Yer Numarası RM301.25 .B56 2020 EB<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119187547">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119187547</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Inducing targeted protein degradation : from chemical biology to drug discovery and clinical applicationsent://SD_ILS/0/SD_ILS:5979892026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Cromm, Philipp, editor.<br/>Yer Numarası RM301.25 .I53 2023<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527836208">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527836208</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Bioanalytical aspects in biological therapeuticsent://SD_ILS/0/SD_ILS:5975572026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Xu, Xiaohui, Ph.D., editor. Xu, Weifeng (Director at Merck), editor.<br/>Yer Numarası RM301.25 .B56 2022<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119523246">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119523246</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Solid state development and processing of pharmaceutical molecules : salts, cocrystals, and polymorphisment://SD_ILS/0/SD_ILS:5970462026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Gruss, Michael, author.<br/>Yer Numarası RS403 .G78 2022<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527823048">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527823048</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Analytical scientists in pharmaceutical product development : task management and practical knowledgeent://SD_ILS/0/SD_ILS:5960472026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Xiao, Kangping, author.<br/>Yer Numarası RM301.25 .X53 2021<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119547785">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119547785</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Controversial statistical issues in clinical trialsent://SD_ILS/0/SD_ILS:5475542026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Chow, Shein-Chung, 1955, author.<br/>Yer Numarası RM301.27 .C475 2011<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439849620">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Dose Optimization in Drug Developmentent://SD_ILS/0/SD_ILS:5469742026-02-23T06:01:52Z2026-02-23T06:01:52ZYazar Krishna, Rajesh, editor. Taylor and Francis.<br/>Yer Numarası RM301.8 .D67 2006<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429136016">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>